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Abstract
Aims: Sporadic human cerebral small vessel disease (SVD) commonly causes stroke and 
dementia but its pathogenesis is poorly understood. There are recognised neuroimaging 
and histopathological features. However, relatively few studies have examined the rela-
tionship between the radiological and pathological correlates of SVD; better correlation 
would promote greater insight into the underlying biological changes.
Methods: We performed a systematic review to collate and appraise the information de-
rived from studies that correlated histological with neuroimaging- defined SVD lesions. 
We searched for studies describing post- mortem imaging and histological tissue exami-
nation in adults, extracted data from published studies, categorised the information and 
compiled this narrative.
Results: We identified 38 relevant studies, including at least 1146 subjects, 342 of these 
with SVD: 29 studies focussed on neuroradiological white matter lesions (WML), six on 
microinfarcts and three on dilated perivascular spaces (PVS) and lacunes. The histopa-
thology terminology was diverse with few robust definitions. Reporting and methodol-
ogy varied widely between studies, precluding formal meta- analysis. PVS and ‘oedema’ 
were frequent findings in WML, being described in at least 94 and 18 radiological WML, 
respectively, in addition to myelin pallor. Histopathological changes extended beyond the 
radiological lesion margins in at least 33 radiological WML. At least 43 radiological le-
sions not seen pathologically and at least 178 histological lesions were not identified on 
imaging.
Conclusions: Histopathological assessment of human SVD is hindered by inconsistent 
methodological approaches and unstandardised definitions. The data from this system-
atic review will help to develop standardised definitions to promote consistency in human 
SVD research.
K E Y W O R D S
cerebral small vessel disease, neuroimaging, neuropathology, radiology, systematic review, 
vascular dementia
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INTRODUC TION
Sporadic cerebral small vessel disease (SVD) is a common finding in 
the ageing brain, defined by neuroimaging features [1] and a range of 
histological lesions [2,3]. While critical to providing a uniform struc-
ture to future research, where histopathological definitions are de-
fined, particularly Skrobot et al. [2], there is no attempt at gradation, 
and they are defined in the context of a single clinical outcome, cog-
nitive decline. Clinically significant, SVD causes 25% of ischaemic 
strokes [3] and 85% of intracerebral haemorrhage [4]. It is the major 
cause of vascular dementia (VaD) [5] and is associated with a range 
of other cognitive [6,7] and physical problems [8,9].
Small vessel disease is best visualised in vivo using magnetic reso-
nance imaging (MRI). An international working group from the Centres 
of Excellence in Neurodegeneration developed definitions and imag-
ing standards for markers and consequences of SVD identifying white 
matter hyperintensities (WMH), lacunes, enlarged perivascular spaces 
(PVS), microbleeds and at high field, microinfarcts [1,10].
Currently, there is no comparable consensus document regarding 
histological SVD lesions [11]. Variation between MRI appearances 
and histopathology may reflect this lack of consistency in definitions 
or may be a consequence of the scarcity of studies detailing the pa-
thology of imaging- detected lesions [12]. Additionally, early stage 
disease may be under- reported and most autopsy- identified lesions 
may be end- stage ‘scars’ [13]. Genetic abnormalities and molecular 
pathways [14,15] have been identified, reflecting the heterogeneous 
underlying pathophysiology [16]. Potential mechanisms for vascular 
and tissue damage include blood– brain barrier (BBB) dysfunction 
[17,18], para- and peri- vascular space abnormalities [19,20] and ab-
normal perfusion [21,22]. However, precise mechanisms at different 
stages and in different lesions remain unclear.
Some lesions are clearly identified by both MRI and histology, 
such as lacunes [2], PVS [23] and small infarcts [24]. Others, like early 
stage WMH, are easily observed on MRI but difficult to detect histo-
logically, contributing to apparent discrepancies about lesion compo-
sition, notably water content and axon degeneration when assessed 
by histology and MRI respectively. Damaged micro- vessels (i.e. arte-
riolosclerosis, lipohyalinosis, fibrinoid necrosis and cerebral amyloid 
angiopathy [CAA]) are below current imaging resolution thresholds 
[2,25,26], but are key descriptors in histological assessment.
Detailed imaging- histological correlations, particularly of indi-
vidual lesions and subtypes, are required. We aimed to summarise 
current knowledge of precise MRI- histological correlations in com-
mon SVD lesions, to assess their reliability and generalisability and 
identify where greater consistency in methodology and definition 
is needed.
METHODS
In this systematic review, we identified all studies correlating ex vivo 
medical imaging with histopathology of SVD lesions. Given the dy-
namic nature of SVD during life, we focused on studies that used 
ex vivo imaging to avoid extended timelines between imaging and 
histology.
Search terms
We searched for the terms ‘small vessel disease’, ‘SVD’ and all rel-
evant commonly used neuroradiological [1] and histopathological 
terms (Table 1), in the Medline online database from its inception 
in 1966 to the 9 September 2020. The search terms were refined 
through several iterations to ensure all relevant SVD lesions on 
imaging and histology were included, and that all potential lesion 
types were included (Table 1). We hand- searched reference lists 
in textbooks, review papers and two relevant journals (Stroke and 
Neuropathology and Applied Neurobiology) and for relevant primary 
publications.
Inclusion/exclusion criteria
We included all studies published in full which carried out post- 
mortem computerised tomography (CT) or MR imaging and histo-
logical examination of adult human brain tissue to study sporadic 
SVD (Figure 1). We excluded: studies reporting only biopsy mate-
rial; studies performing post- mortem imaging but no histopathology 
or vice versa; studies not reporting on human sporadic SVD; non- 
English publications; and studies of haemorrhagic SVD lesions only 
as these were reviewed recently [27,28]. We excluded all duplicate 
publications, editorials and conference abstracts. Where studies 
came from the same groups and it was not clear which, if any, cases 
were included more than once, we included only the largest study 
for subject characteristics and results, and only distinct individual 
findings from the other papers.
Quality of reporting
To assess methodology quality, we adapted the Standards for the 
Reporting of Diagnostic Accuracy studies (STARD) criteria [29] for 
observational studies to give a score out of 25. Information was ex-
tracted regarding the authors expertise, aims, the study population, 
study dates, data collection, participant recruitment, pathological 
and radiological methods, blinding, analysis, results reporting and 
discussion of findings (Table 2). Each individual feature could gain 
one point, or part thereof if only part of the criteria was met. The 
authors discussed and resolved uncertainties regarding inclusion, 
exclusion and scoring when required.
Data extraction
Data were extracted from study characteristics including study 
design and dates, prospective or retrospective recruitment, data 
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collected, sample size, blinding and analysis methods. Subject data 
included demographic and clinical data including cognitive status, 
in vivo investigations, age, gender and ethnicity. Radiological spe-
cifics included scanner field strength, sequence resolution, tissue 
scanned, measures to avoid artefact and involvement of neuroradi-
ologists. We collected details of pathological processing, assessment 
of tissue quality, macroscopic examination, staining, grading systems 
used, terminology and definitions and involvement of neuropatholo-
gists. All three authors read the papers and had regular meetings 
to agree a consistent approach and achieved consensus through 
discussion.
Various pathological terminologies were used in the pa-
pers, not always consistently, hence we condensed the infor-
mation into manageable categories based on the terminologies 
in each paper. For reference, we provide a full list of the terms 
encountered and similar expressions in Table S1. We recorded 
the method used to relate tissue locations on MRI/CT to that 
on histology, the analyses used and the neuroradiological– 
neuropathological findings.
RESULTS
The initial search yielded 1627 articles: 16 duplicates were removed, 
and we excluded 1403 papers including 37 studying monogenic SVD 
(reasons detailed in Figure 1). For interest, the excluded papers that 
studied monogenic SVD are listed in the supplement, two of which 
compared lesion appearances on post- mortem imaging and histol-
ogy [30,31]. Searching reference lists of 183 review papers provided 
nine additional relevant papers, and two further papers were identi-
fied from hand- searching journals. This resulted in 38 relevant pa-
pers, that reported imaging of at least 1146 individual patients in 
total, 342 of whom had SVD lesions on imaging. Studies were pub-
lished between 1986 and September 2020, all using ex vivo MRI 
(Table 3). Of these we created three groups; 29 primarily focused on 
imaging- identified white matter lesions (WML), six studying microin-
farcts and three on PVS and lacunes.
The information provided varied between studies. There were 
insufficient numerical data to perform a meta- analysis. Only one 
group clarified subject duplication between papers [32,33]. We 
Results Search
1 exp Brain/pa, pp [Pathology, Physiopathology]
2 *Cerebrovascular Disorders/pa [Pathology]
3 *Stroke, Lacunar/et, pa, pp [Etiology, Pathology, Physiopathology]
4 (cerebrovascular disease or cerebrovascular lesions or cerebrovascular 
pathology).ti,ab.
5 SVD.ti,ab.
6 small vessel disease.ti,ab.
7 lipohyalinosis.ti,ab.
8 arteriolosclerosis.ti,ab.
9 (atherosclerosis adj3 small*).ti,ab.
10 CAA.ti,ab.
11 cerebral amyloid angiopathy.ti,ab.
12 (WMH or white matter hyperintensit$).ti,ab.
13 (WML or white matter lesion$).ti,ab.




18 small deep infarct.ti,ab.
19 fibrinoid necrosis.ti,ab.
20 (histopatholog$ or histolog$ or patholog$).ti,ab.
21 (IHC or immunohistochemi$).ti,ab.
22 (ICC or immunocytochemi$).ti,ab.
23 1 or 2 or 3
24 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 
or 18 or 19
25 20 or 21 or 22
26 23 and 24 and 25
27 limit 26 to humans
TA B L E  1  Final search strategy
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included only the largest study when there was possible duplica-
tion and it was not possible to extract precise subject data.
Study quality
The mean quality score was 14/25 (range 6– 19) (Table 3; Figure 2). 
Study aims, radiological definitions, statistical analysis, distribu-
tion of severity and discussing the scientific importance were well 
reported, and all papers described some degree of radiological 
methodology. Study dates, participant recruitment methods, tis-
sue quality assessment, blinding of radiological assessment and ad-
dressing radiological artefact were not consistently reported. One 
study reported participants’ race (all female Caucasians) [34]. None 
reported tissue quality assessment beyond recording post- mortem 
interval (PMI) to autopsy.
Study characteristics
Subjects and SVD lesions
Of the 38 papers identified, 28 studied WML based on the MRI- identified 
WMHs, one additional study compared white matter MRI diffusion ten-
sor imaging (DTI) changes with histological measures and was included 
here. Six studied microinfarcts, and three studied PVS and lacunes.
The WMH/WML studies were from 21 groups in 11 countries 
(Table 3). They included at least 895 subjects, (at least 277 of whom 
were female) aged 45– 101, at least 313 of these had SVD on imaging.
The microinfarct studies were from four groups in different 
countries, including at least 202 subjects [35– 40]. Four papers di-
rectly compared lesions identified on MRI with histology [37– 40]. At 
least 19/202 subjects had microinfarcts although it was not possible 
to determine how many had lesions in two papers [35,36]. The age 
range was 62– 98 years in the three papers where age could be cal-
culated or was given [37,39,40].
The studies reporting on PVS and lacunes were from different 
groups [33,41,42] and included 53 subjects in total, although four 
subjects [42] also appear to have been reported in a paper studying 
microinfarcts [39]. Ten subjects had PVS and/or lacunes, six of these 
were female. Ages ranged from 37 to 90 years.
Haemorrhagic pathology identified within the studies included is 
not reported here because it was not consistently reported, particu-
larly where it was not the focus of a paper. Recent detailed reviews 
of haemorrhagic SVD pathology have been published and better 
serve to describe the relevant lesions [27,28].
Data collection
Twelve studies collected subjects’ data retrospectively (Table 3; 
Figure 2) from different, often multiple, sources including medi-
cal notes [37– 39,41– 49], cause of death (not specifically stated 
where these data were obtained) [37,44,48– 50], autopsy reports 
[38,39,44,45] and interviewing relatives [46]. Many did not report 
how or when subject data were collected [32,33,35,36,40,51– 58]. 
Ten studies collected clinical information prospectively [34,59– 67], 
and one provided no subject information [68].
F I G U R E  1  Summary of a literature 




Reporting of SVD risk factors and conditions affecting subjects in 
life was variable. Twenty- one of the 38 papers reported individual 
subject data for each subject with SVD [32,33,37– 42,44– 49,51– 5
3,55,62,66,69], 13 of which included SVD risk factors (Figures 2 
and 3) [33,37,38,41,44– 48,52,53,62,66]. SVD risk factors were 
not reported in some or all of the subjects in 13 of the 38 stud-
ies (Figures 2 and 3) [34,40,42,49,54,55,58– 61,67– 69], mostly 
community- based cohorts of older subjects with dementia or other 
neurodegenerative conditions and controls, or unselected subjects. 
The presence of hypertension, stroke, ischaemic heart disease and 
conditions predisposing to thrombus formation was reported most 
often (Figure 3).
Radiological– histological correlation
A range of methods were used to compare imaging and histologi-
cal lesions. Attempts to make the lesion comparisons more precise 
involved using computer software to guide brain cutting, using 
topographical features to select lesions [51], or software aligning the 
MR image to histology then overlaying the images to identify areas 
of interest [62]. One study described specifically using only samples 
where the precise matching sulcal pattern could be identified [57]. 
Ferrous [46] and plastic [58] markers were also used to increase the 
precision of cutting planes.
Most frequently, MRI was used to guide sampling for histolog-
ical examination [43– 45,52,53,61,64,66,67,70]. Where the whole 
brain was scanned, radiologists were sometimes present at the 
brain cut [32,49], with additional brain slice scans after cutting in 
one paper [48]. Brain slices were imaged then sampled in some 
studies [47,56,59,64,67], three also described measures to slice 
the brain at the same thickness as the MR slice [44,46,49]. The 
whole brain was scanned and assessed with routine predefined 
samples taken for histology in five studies [34,50,54,58,65]. One 
study imaged hemispheres then carried out whole hemispheric 
histological sampling [55], another imaged hemispheres and 
chose MR regions of interest corresponding to the histological 
samples taken [69], and one scanned individual histological tissue 
blocks that were processed afterwards [40]. No description of 
the correlation technique was given in one paper [68], whereas 
TA B L E  2  Quality assessment
Title Neuropathologist and neuroradiologist in the authors
Introduction State the research questions or study aims
Methods
Participants Describe the study population: inclusion and exclusion criteria, setting and locations where the data were collected
Report when the study was done, including beginning and ending dates of recruitment
Describe participant recruitment
Describe data collection: prospective or retrospective
Pathology Describe the pathological methods: rationale, technical specifications (and/or cite references)
Define pathological lesions and criteria used for assessments
Describe the number and expertise of the persons executing the macroscopic and microscopic neuropathological assessment
Were the individuals carrying out the macroscopic and microscopic assessment blinded to the results of other assessments 
and any other available information?
Assess PM tissue quality and/or report post- mortem interval
Imaging Describe the radiological methods: rationale, technical specifications (and/or cite references)
Define radiological lesions and criteria used for assessments
Describe the number and expertise of the persons executing the radiological assessment
Were the assessors blinded to the results of other assessments and any other available information?
Describe measures taken to minimise artefact on MRI
Statistics Describe statistical methods for calculating or comparing measures of diagnostic accuracy, adjusting for variables, and the 
statistical methods used to quantify uncertainty (e.g. 95% confidence intervals)
Results
Participants Report clinical and demographic characteristics of the study population (e.g. age, sex, race, clinical info etc.)
Report characteristics for individual subjects
Report clinical features associated with SVD
Results Report the distribution of disease severity
Report a cross- tabulation (including indeterminate and missing results)
Discussion Discuss the clinical applicability and/or use of the findings
Discuss the scientific importance use of the findings
Discuss the future use of the findings
Note: Adapted from the Standards for the Reporting of Diagnostic Accuracy studies checklist. Each feature assessed could gain 1 point, or a part 
thereof if the only part of the data was reported up to a total score of 25.
Abbreviations: MRI, magnetic resonance imaging; SVD, small vessel disease.







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































one reflected that 10 mm MR slices were not comparable to the 
micron scale of histological slices [47].
One paper that included both in vivo and ex vivo imaging with-
out clarifying which results were obtained from which method 
[43] was included as the imaging was of high quality. One subject 
in one paper underwent imaging 11 days prior to death and al-
though imaging could not be undertaken post- mortem, this case 
was included in the results without distinction from those with ex 
vivo MRI [51]. We felt this paper provided unique and important 
data and should be included within our review despite this. One 
paper reported two studies that were undertaken, but only the 
second study used post- mortem MRI and is included here [66].
MR methods
Ex vivo scanning
All used MRI, most at 1.5 Tesla (T) [32,33,41,43– 45,50– 53,56– 58, 
68], with the majority scanning the whole brain [32– 34,41,43– 46,48
– 52,54,57,58,66,68]. One study used a diffusion- weighted sequence 
at 3T [69]. Several scanning mediums were used, including water 
[32,33,36,40,45,48,62], formalin [37– 39,42,50,51], sealing the tissue 
in plastic [59– 61,63,64,67] or placing between plastic sheets [56]. 
However, most studies did not state which scanning medium was used 
[34,41,43,47,49,52– 54,65,68]. Tissue was scanned in air in four papers 
F I G U R E  2  Bar chart showing how often the features used to measure study quality (detailed in Table 3) were reported in the studies 
included. Bars indicate the number of papers reporting each feature. The number that reported and fully met the criteria in Table 3 (dark 
blue), partly met the criteria (middle blue) or did not report that feature (light blue)
F I G U R E  3  SVD risk factors and associated clinical diagnoses for individual subjects were reported in only 13 of the papers in this study. 
Some papers reported more than one risk factor, some only one. This figure shows the frequency with which each risk factor was reported. 
Hypertension, a predisposition to thrombus formation, stroke and ischaemic heart disease were reported most often. The block indicating 
hypertension begins at 12 o'clock and proceeds clockwise in the same order indicated in the key. SVD, small vessel disease
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[44,46,55,57], but some specifically avoided air due to artefact. Eleven 
studies took measures to avoid introducing MR artefact, usually by re-
stricting tissue movement [35,36,66,69] (e.g. by wrapping in cling film 
[59,63,64,67]), or artefact due to air bubbles [38,39], by running a hand 
over the tissue [62], shaking the tissue [37], tilting to eliminate air from 
the ventricles [45] or vacuum sealing [69]. One study tested a variety 
of methods to reduce artefact, concluding water at 37°C was optimal 
and that embedding in agar, extended washing to remove formalin and 
removing the pia had no effect [40].
Establishing ex vivo MR parameters
One brain was scanned ante- mortem and post- mortem after fixation, 
and the same areas of hyperintensity were identified without obvious 
differences [54]. Two post- mortem brains scanned before and after 
fixation had identical WML appearances [51]. Three studies used clini-
cal scanning protocols at post- mortem [40,45,52] and some described 
using optimised sequences, but without giving details [37,39,47,59– 
61,63,64,67]. T2- weighted sequences were said to be best for visu-
alising WML ex vivo [52], whereas nine studies performed ex vivo 
fluid- attenuated inversion recovery (FLAIR) [38,39,43,46,47,50,60], 
two of which described protocol optimisation [62,66].
One study found a diluted formalin/water scanning medium was 
hyperintense on short TR sequences, compared to hypointense ce-
rebrospinal fluid [33] and another stated that changes in signal inten-
sity due to fixation made identification of lacunar infarcts difficult 
[53]. Only one study described optimisation of a T1 sequence [38].
In vivo imaging
A total of 105 subjects in five papers primarily studying WML had in vivo 
MRI available [32,43,51– 53], of which at least 17 subjects also under-
went ex vivo MRI and 15 additionally had in vivo CT [32]. In two papers 
studying PVS and lacunes, nine subjects underwent in vivo MR imaging 
and 20 had in vivo CT [33,41]. In one paper studying microinfarcts, al-
though 12 subjects had both in vivo and ex vivo MRI carried out, com-
parison of the microinfarcts was possible in only one subject [37].
Autopsy and histological methods
Post- mortem
The PMI was reported in 14 studies and ranged from <24 h [34,40, 
44,46,48,49,55,64,66,67,69] to 7 days [64]. Most studies had mul-
tiple cases, and PMIs varied considerably within each study. The 
most common method of fixation was to fix the whole brain in a 
variety of formalin solutions [32– 39,41– 52,54– 63,65– 69] although 
one study did not describe how the tissue was fixed [64]. The dura-
tion of tissue fixation ranged from slices in a formalin solution over-
night [56] to slices formalin fixed for 12 years [47]. One study noted 
that the MR image quality was not affected by different fixation 
periods from 9 to 35 days [46] and when the time between death 
and scanning was controlled for statistically, it did not alter the re-
sults obtained by DTI in cases ranging from 27 to 498 days [69]. 
Assessment of post- mortem tissue quality using methods such as 
pH or RNA- integrity number measurement was not reported. Three 
papers commented on storage temperatures; one cooled brains 
after autopsy [56], one stored them at room temperature [34] and 
the third stored hemispheres at 4°C until the day before scanning 
when they were transferred to room temperature [69].
Macroscopic examination
Nineteen studies described macroscopic examination 
[32– 35,41,44– 52,54,57,58,62,65] including photography 
[32,33,47,51,54], brain weight [34,45,47– 49,51,52,58,62,65] 
or describing some general aspect of macroscopic inspection 
[34,35,41,44,46,47,49– 51,54,57,58,62,65].
Staining and special techniques
All papers described using special tinctorial or immunohistochemi-
cal staining to characterise tissue lesions. Haematoxylin and eosin 
was most often used for general tissue architecture [32,33,37– 41, 
43,44,47– 49,51,52,54,55,57– 60,62– 64,66,69] followed by myelin 
stains, particularly Luxol fast blue [34,38,39,41,43– 48,51,52,54– 56,
59,60,62– 64,69], glial stains [39,43,45,46,48,51,54,62– 64,68,69,71] 
and a variety of neuronal, microglial, endothelial and amyloid stains. 
More recently, papers trying to assess specific mechanisms such as 
inflammation, hypoxia and BBB, have used a wider range of markers 
to assess the different pathways [54,59– 61,63,64,66,67].
Pathological terminology and definitions
Pathological lesions were less well defined than MRI lesions (Figure 2). 
The histopathological definitions and terminology used were variable 
between papers (see Table S1 for full library of terms), so we have 
had to apply a degree of interpretation, aiming to group lesions as ob-
jectively as possible by their morphological appearance and staining 
characteristics rather than the presumed underlying cause.
A range of histological findings were described corresponding to 
radiological SVD (Figure 4A), most often a variety of WM changes 
including myelin and axon pallor (Figure 5), microscopic ‘abnor-
malities’, rarefaction and degeneration. Radiological WMH corre-
sponded to several histological appearances (Figure 4B), typically 
more than one. In particular, the range of terminology describing 
vascular pathology of radiological WMH was wide and often poorly 
defined (Figure 4C).
Perivascular spaces, also known as Virchow– Robin spaces, 
(Figure 6) were defined in two of the three papers studying them 
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specifically as the subarachnoid space around small vessels in the 
brain excluding capillaries [33,41]. Enlarged PVS were described 
as a marker of SVD and defined as spaces filled with interstitial 
fluid surrounding these vessels [42]. État pre- criblé was described 
as thin, pale and sinuous myelin in surrounding parenchyma, with-
out PVS dilation. Subsequent rarefaction and disintegration of 
the perivascular parenchyma [33] resulting in état criblé in which 
PVS are dilated. Associated surrounding changes may be present, 
F I G U R E  4  Histological lesions and 
terminology. For clarity and to avoid 
many small groups, some headings 
contain terms used to describe similar 
pathologies, some of which were not 
specifically defined and reflect the 
variation of terminology summarised in 
Table S1, for example ‘WM abnormalities’ 
include rarefaction, myelin pallor, 
demyelination, abnormal myelin sheaths, 
degenerate myelin, decreased axonal 
staining, decreased axons and Luxol fast 
blue lesions. BBB, blood– brain barrier; 
CAA, cerebral amyloid angiopathy; 
PVS, perivascular space; WM, white 
matter. (A) Histological lesions described 
microscopically corresponding with 
all radiological small vessel disease 
lesions. (B) Histological lesions described 
microscopically corresponding with 
radiological WM lesions only. (C) 
Histological terminology used to describe 
the spectrum of vessel wall changes seen 
in radiological WM lesions
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including a narrow border of fibrillary gliosis or demyelination 
[33].
Lacunes (Figure 7) were ‘a lesion surrounded by gliosis and myelin 
loss’ histologically [41] or more mechanistically as ‘infarctions caused 
by perforating branch occlusion’ in white and deep grey matter [33]. 
They were also called penetrating branch occlusions and lacunar in-
farcts. In these studies, size was not a criterion [33]. Recent lacunar 
infarcts showed liquefactive necrosis [33] and when older form an 
irregular cavity with fibrillary connective tissue and macrophages, 
which decrease with time [33]. État lacunaire described the presence of 
multiple lacunar infarcts [33] and giant lacunae were defined as >1 cm 
diameter [33].
Six papers studied cortical microinfarcts (Figure 8) using a va-
riety of overlapping definitions, but these papers came from only 
three groups. From defined areas of tissue pallor [37,39] to ‘isch-
aemic necrosis in the territory of a single cortical penetrating ves-
sel’ [35], ischaemic lesions with cell death or necrosis, sometimes 
with gliosis, haemosiderin- containing macrophages and cavitation 
[38,39] or well- defined ischaemia with cell death, necrosis and cav-
itation [40]. One differentiated acute microinfarcts with tissue loss 
and gliosis from old microinfarcts with ischaemic or shrunken neu-
rons [37], but the size was not defined in advance. In the others, sizes 
were described as between 50 μm and 2 mm, depending on the size 
F I G U R E  5  (A) Normal central white matter showing uniform myelin staining (LFB ×100). (B) Central white matter from a case with severe 
small vessel disease, showing pallor and fine vacuolation between axon sheaths (LFB ×100). LFB, Luxol fast blue
(A) (B)
F I G U R E  6  An enlarged perivascular space from the region of 
the central white matter. There is a central vessel with marked 
expansion and fibrillation of the surrounding perivascular space 
(haematoxylin and eosin ×100)
F I G U R E  7  A lacunar infarct (arrow) in the internal capsule with 
gliosis and cystic degeneration, measuring <10 mm in maximum 
diameter (haematoxylin and eosin ×40)
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of the involved vessel [35], or from 50 μm to a few mm [38,39], but 
also as almost visible on gross examination [35,36,39] or microscopic 
[38]. One did not define or describe the histological appearance [36].
Papers studying WMH
Macroscopic comparisons
Where MR- defined WMH were compared with macroscopic ap-
pearances, tissue softening, pallor and loss including infarcts or 
spaces consistent with lacunes or PVS [32,45,47,48,51,54] were 
described most often. However, there were often no obvious 
macroscopic changes [46,48,49,52] or only subtle discolouration 
[47,51]. Macroscopic lesions in one study were on average 54% 
larger than on MRI [44] and were more extensive in another [57]. 
A separate study found differences between areas of high signal 
intensity (discolouration and dilated PVS) and areas of relatively 
lower (but still increased) MR signal change, which could not 
be identified [62]. Naked eye examination of histological slides 
stained for myelin or axons described pallor in areas of radiologi-
cal WMH [50,57].
Precise microscopic comparisons
Twelve papers attempted to make direct comparisons between 
imaging WMH and corresponding histological lesions, and some 
described pathology in specific locations. WMH in the centrum 
semiovale showed variable white matter pathology. WMH in 
seven brains (five with bilateral discrete WMH, two with ‘diffuse 
change’) revealed dilated PVS containing fluid and macrophages, 
myelin and axonal pallor and gliosis [46]. Thirty- three extensive 
WML corresponded with poorly defined areas of myelin pallor 
that appeared larger on histology. They contained axonal swell-
ings and loss, and involved subcortical U- fibres when severe with 
WM vacuolation (‘spongiosis’), decreased oligodendroglial num-
bers and dilated PVS throughout. Twenty- one per cent (n = 7) of 
the extensive WML also contained focal perivascular or scattered 
diffuse vacuolation. One WML was close to a small infarct and one 
contained a small haemorrhage [57]. WML corresponded to my-
elin rarefaction in five brains (three in the centrum semiovale, two 
periventricular). All five brains had moderate- severe lipofibrohya-
linosis and one had diffuse WM oedema in the centrum semiovale 
[53]. Seven WML corresponded with histological infarction; one 
of which had surrounding gliosis correlating with the WML, one 
was recent with early cavitation, macrophages and surrounding 
gliosis [32] and two in the left frontal WM were old with a 1 cm 
cavity and 3 cm of surrounding gliosis. An unspecified number of 
small intermediate and old infarcts with surrounding isomorphic 
gliosis were also found in frontal, mid- coronal and occipital WM 
[54]. One cerebellar WMH corresponded with a 3 cm infarct histo-
logically [54]. ‘Isomorphic gliosis’ and IgG in astrocytes extended 
up to 3 cm from old infarcts (showing cavitation and minimal 
gliosis, some with demyelination) and the ventricles [54]. Pontine 
WMH revealed severe gliosis and axonal and myelin loss [47]. 
Periventricular WMH contained myelin pallor, dilated PVS, sub-
ependymal gliosis and increased extracellular spaces accompany-
ing disrupted ependymal [68].
The locations of some lesions and pathologies were not speci-
fied. One study sampled 27 radiological WMH from 16 brains (cen-
trum semiovale in two brains, adjacent to the frontal horns of the 
lateral ventricles in two, optic radiations in five and basal ganglia in 
three; the number of samples per brain/area is not described). 100% 
of WMH sampled (n = 27) contained at least one severe pathology of 
arteriolar sclerosis, vascular ectasia or dilated PVS [51], 85% (n = 23) 
had two severe changes. Fifty- nine per cent (n = 16) also showed 
subependymal gliosis, associated with myelin pallor, axonal loss, di-
lated PVS, vascular ectasia and arteriolosclerosis. In 15 control areas 
sampled, 27% (n = 4) had one severe pathology and 7% (n = 1) had 
two severe changes [51]. In another study, 141 deep subcortical 
WMH showed severe myelin pallor and damage [59]. Of nine larger 
(not punctate) subcortical WMHs, 78% (n = 7) showed prominent 
myelin pallor and PVS with parenchymal oedema, 67% had gliosis 
(n = 6), 44% macrophage infiltration (n = 4) and 33% arteriosclero-
sis (n = 3). Twenty- six per cent (n = 5) of punctate WMH showed 
periarteriolar demyelination often surrounding enlarged PVS and 
16% (n = 3) had perivenous demyelination. At least one was in the 
external capsule [52]. In another paper, deep and subcortical WML, 
both punctate and confluent, corresponded with histological myelin 
pallor and dilated PVS [68].
One paper was difficult to interpret but seemed to identify six in-
farcts, four old and two recent [48]. Two small areas in the corona ra-
diata showed recent infarction with macrophages and inflammation 
F I G U R E  8  A cortical microinfarct (arrow) with localised tissue 
loss and reactive gliosis, the lesion being found on microscopic 
examination but not visible to the naked eye examination 
(haematoxylin and eosin ×100)
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surrounded by degenerate myelin, and one cystic area in the internal 
capsule corresponded to a dilated PVS containing an ectatic, scle-
rotic artery and macrophages with surrounding fibrous gliosis [48].
In surrounding, radiologically non- lesional tissue, there were 
eight areas of enlarged PVS, five parenchymal oedema and four of in-
flammation [45], and two areas of histological gliosis/non- cavitated 
minute infarction were adjacent to areas of fibre loss with fibrillary 
necrosis and cavitated, gliotic infarcts [32]. Eleven per cent (n = 10) 
of control samples contained intermediate necrotic lesions with sur-
rounding gliosis [54]. In tissue adjacent to six punctate WML, 50% 
(n = 3) contained dilated PVS, 33% (n = 2) gliosis and 17% (n = 1) each 
with arteriosclerosis and myelin pallor [45].
Binswanger's disease described radiologically as ‘irregularly 
distributed WML relatively sparing the temporal lobe’ showed his-
tological moderate rarefaction with loss of myelin, axons and oligo-
dendrocytes, and mild gliosis and arteriosclerosis [68].
Radiological DTI abnormalities replicated those seen in vivo 
and were associated with the presence of microinfarcts in posterior 
white matter. Abnormal fractional anisotropy was more sensitive to 
axonal loss, whereas increased mean diffusivity reflected myelin loss 
in CAA [69].
An assortment of other histological lesions appeared as radiolog-
ical WML. Several so- called lacunae were identified: one with gliosis 
and myelin pallor surrounding 2 mm central area of necrosis [51]; 
one in the temporo- parieto- occipital deep WM with dense gliosis 
surrounding a cystic area [47]; two WMH in the globus pallidus and 
putamen corresponded to two lacunar infarcts with the same size on 
imaging and histology [54]; a poorly circumscribed, irregular WML 
with a halo of signal intensity was a poorly defined cystic cavity with 
surrounding mild gliosis [68]; a large circumscribed area of low sig-
nal in the putamen showed an empty cyst with previous haemor-
rhage [47] and multiple lacunae were found in the basal ganglia of 
three brains and the thalamus in two brains [53]. A circumscribed 
linear WMH smaller than 3 mm without surrounding signal change 
was a dilated PVS [68]; 88% (n = 15) of punctate centrum semiovale 
WMH contained dilated PVS on microscopy, 6% (n = 1) had small 
infarcts and CAA, whereas no histological abnormality was found 
in 6% (n = 1) [57]. Punctate WML additionally represented defined 
areas of demyelination, two subcortical ganglion cell heterotopias, 
one periarteriolar fibrosis and one perivenous oedema [52]; one case 
with telangiectasia [51] and two areas of demyelination, one cyst and 
one congenital ventricular diverticulum [32].
Histological cribriform changes, with a sieve- like pattern of 
‘holes’ of varying sizes in the basal ganglia (status cribrosum) were 
seen in eight subjects: 38% (n = 3) in the presence of radiological 
lacunes, 25% (n = 2) with a single radiological lacune but without 
any MRI correlate in 38% (n = 3). This could reflect the low resolu-
tion of the MRI with a 1T field strength and 5 mm slice thickness 
[53].
There were a number of post- mortem imaging- histology mis-
matches. Radiological lesions not identified on histology included 
36 WMH [32,52,59] plus multiple lacunes in the centrum semiovale, 
brainstem and cerebellum [53]. Histology revealed lesions not seen 
on imaging: 37 deep subcortical WM areas with moderate myelin 
loss and endothelial activation [59], three infarcts [32,48], two basal 
ganglia lacunes plus one white matter infarct and two small old cor-
tical infarcts, with cribriform change in the cerebellum, basal ganglia 
and pons [53].
Vascular pathology
A range of vasculopathies were described in MRI WML (Figure 4C) 
and were often associated with other lesions but not correlated to 
the other changes. Atherosclerosis was common in periventricular 
lesions, with vacuolation and gliosis in neurologically normal cases 
in one study [48]. WML in four subjects contained lipofibrohyalino-
sis and CAA [53], two subjects additionally showing patchy, rare-
fied myelin. Lipofibrohyalinosis and CAA were also seen, however, 
in subjects without MRI WMH. Differing severities of angiofibro-
sis, hyalinosis and arteriosclerosis were present in 83% (n = 5) of six 
brains in another study, the remaining brain contained angiofibrosis 
and arteriosclerosis only [52].
Six punctate WMH examined in deep grey or white matter all 
showed enlarged PVS and perivascular gliosis. Two thirds of these 
WMH contained vascular ectasia, one third had perivascular in-
flammation and half arteriosclerosis [45]. Eight linear periventric-
ular WMH, <2 mm thick, all contained prominent subependymal 
gliosis [45] and six focal WMH (<5 mm) at the poles of the lateral 
ventricles showed myelin pallor with arteriosclerosis and gliosis. 
Two thirds of the focal WMH had enlarged PVS, and one each had 
adjacent arteriolosclerosis, oedema and inflammation [45].
In vivo imaging in WML
Fazekas et al. noted many small WML (<5 mm diameter) in their 
study that would not have been identified post- mortem without 
knowledge of in vivo MR [52]. In vivo MR also appeared superior at 
detecting hypointensities [53]. In vivo CT did not identify a 4 × 4 mm 
area of gliosis/infarction, two areas of demyelination and one cyst 
measuring 6 × 6 mm which were subsequently seen on ex vivo MRI 
[32].
Non- precise WML comparisons
Deep subcortical WML showed a range of non- specific changes, par-
ticularly myelin pallor, vacuolation, decreased cellularity and dilated 
PVS [45,46,57,59,63,68], with more vasculopathies, including arteri-
olosclerosis, compared to periventricular WML [45]. Periventricular 
WML were associated with disruption of the ependymal [60,63], ab-
normalities in myelin, axons and astroglia [46,62,63], and sometimes 
with increased subependymal gliosis [45,68]. Overall, WML were 
larger on MRI than histology [41,54], usually of the order of about 
25% with gliosis contributing to the MR appearance [32,54,68], 
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Some histological studies suggested roles for inflammation, BBB 
dysfunction and hypoxia in both periventricular and deep subcorti-
cal WML [60,62– 64,66].
Radiologically normal- appearing white matter (NAWM) in 
subjects with WML was studied in some papers. It was histologi-
cally abnormal immediately adjacent to lesions [44,45,59], where 
it may represent a transitional zone, but also distant to lesions 
[64]. However, specific distances from WML, or graded changes 
as the distance increased, were not addressed. Suggested mech-
anisms included a global underlying pathology, possibly involving 
endothelial activation and inflammation. White matter in sub-
jects without WML appeared normal with strong myelin staining 
in several studies [44,54,59]. Microglial staining characteris-
tics and morphology differed between deep subcortical WML, 
NAWM and controls [67].
WML summary
• Macroscopic changes of WML include discolouration and soften-
ing but often no lesion was visible.
• Location of lesions was frequently not described; descriptions 
were sometimes difficult to interpret and overall difficult to 
summarise and compare due to differences in terminology and 
reporting.
• Location of lesions was most often described in the centrum 
semiovale.
• Microscopy of radiological WML commonly included myelin pal-
lor, oedema and PVS dilation (Figure 5), as well as areas of tissue 
infarction and cavitation. Vascular pathology and inflammation 
were also seen.
• Gliosis contributes to hyperintensity on post- mortem MRI.
• Few studies have made precise comparisons of the gradation of 
histology from lesional to normal appearing tissue, and of radio-
logically NAWM in lesional brains.
Papers studying dilated PVS and lacunes
Three studies specifically reported dilated PVS and lacunes 
[33,41,42], two of which compared lesions identified on 1.5T MR 
with histology, on morphology and size [33,41]. Macroscopic ex-
amination confirmed the morphology seen on MR imaging [33].
Precise microscopic comparisons
At least five radiologically identified lacunes corresponded to micro-
scopic cavities with surrounding gliosis and axon loss [47,48,68]; two 
also had perilesional macrophages and lymphocytes with neovascu-
larisation [48]. Using a 1.5T scanner, one study described the hyper-
intense halo on MR corresponding with surrounding, partial myelin 
and axon loss, and gliosis [68].
Vascular pathology
Microscopic vascular wall pathology was not described.
Location
Lacunar infarcts and PVS were both more common in the basal ganglia 
and thalamus. Eighty- two lacunar infarcts were studied in total: 47 in 
the basal ganglia and thalamus, 24 in the white matter and nine in the 
posterior fossa [32,33,41,48,53,54]. Sixty- seven PVS were identified 
in one paper, 58 within the basal ganglia [41]; a second paper found 
four areas of dilated PVS in the putamen and white matter [33].
Size and morphology
Studies that compared size and morphology used 1.5T and a 
5 mm slice thickness [33,41] or 0.35T and 0.95 mm resolution 
[54]. Lacunes were consistently larger than 2 mm in their greatest 
dimension on both MRI and histology [33,41], and were largest 
in the deep grey matter (3 × 1 mm to 14 × 13 mm), followed by 
posterior fossa (3 × 1 mm to 5 × 3 mm), being smallest in the white 
matter (2 × 2 mm to 4 × 2 mm) [33,54]. Their dimensions were the 
same on histology and ex vivo MRI [54] and they were most com-
monly wedge- shaped, but this was variable with slit- like, round 
and ovoid morphology also seen [33,41]. PVS were significantly 
smaller than lacunes in all areas studied except in the most caudal 
region of the basal ganglia [41]. PVS were predominantly round or 
linear in shape and <2 × 2 mm on MRI without perilesional signal 
change [68].
In vivo imaging
In vivo neuroimaging was performed in 26 subjects; 36 MRI le-
sions were identified and confirmed on pathology in six subjects 
[41]. In vivo CT identified all six histological lacunar infarcts in the 
basal ganglia and one of five in the WM, confirming their morphol-
ogy, but did not identify any in the brainstem or areas of status 
cribrosum [33].
Dilated PVS and lacunes summary
• Five radiological lacunes were histological cavitated lesions 
(Figure 7).
• Lacunar infarcts and PVS were both more common in the basal 
ganglia and thalamus.
• Radiological lacunes were sometimes surrounded by signal 
change and were larger than 2 mm.
• Dilated PVS on MRI were smaller than lacunes (<2 × 2 mm) with-
out perilesional signal change.
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MRI- histopathological correlations on microinfarcts
A total of 570 microinfarcts were identified on MRI in 202 subjects, 
69% (n = 396) of these from a single paper (we have calculated this 
figure from subject numbers and group means) [35]. The number 
of microinfarcts per subject ranged from 0 to 72. Sixty- seven per 
cent (n = 381) were found on histology. Two papers identified 86% 
(n = 327) of these but compared mean numbers between neuro-
degenerative disease subgroups only [35,36]. Twenty- six were 
precisely matched to MR- identified microinfarcts in three papers 
[37– 39]. In another, 49 microinfarcts were initially identified on his-
tology, 35% of these (n = 17) were subsequently found on 3T MRI 
[40]. Those found were all over 2 mm in size, but some microinfarcts 
over 2 mm and all less than 1 mm could not be seen on 3T MRI.
Seven MRI- identified microinfarcts were searched for on his-
tology but not identified, and one was described as an area of rar-
efaction [39]. Fifty- six additional microinfarcts were identified on 
histology only [37– 40]. They measured 0.6 mm diameter on aver-
age, below the current detection threshold for 7T scanners [39]. 
Nine histological microinfarcts were present in one small sample, 
none of which had been identified by ultra- high (100 μm3) resolution 
MRI, although two identified at 300 μm3 resolution were matched 
to histology with no additional microinfarcts being identified [37].
Precise microscopic comparisons
Microinfarct histology within the cortex was heterogenous [39]. 
Three studies identified 84 potential microinfarcts as hyperintense 
cortical lesions on T2 and FLAIR sequences [38] or any lesion smaller 
than 5 mm [39] or both [37]. Twenty- six were confirmed as different 
types of microinfarcts on histology. Fourteen with increased signal 
intensity on T2 and FLAIR sequences revealed histological chronic 
microinfarcts with pallor, gliosis and neuronal loss [37], sometimes 
with incomplete cavitation not visible on MRI [39]. Three were hy-
perintense on T2 and hypointense with a bright rim on FLAIR, his-
tologically revealing fluid- filled cavities surrounded by gliosis. Three 
hypointense lesions on T2, FLAIR and T2* sequences showed histo-
logical haemosiderin- laden macrophages, gliosis and neuronal loss 
[39]. Six acute lesions showed red neurons and WM pallor [37], and 
one was hypo- isointense on T2 and FLAIR [39]. One study stated 
microinfarcts and PVS had similar appearances on MRI, but could 
be differentiated by their location, PVS being just below the cortico- 
medullary junction [40].
Chronic lesions measured 1.2– 2.5 mm [38], smaller than the 
single acute microinfarct measuring 4.4 mm. Sizes were not signifi-
cantly different between MR and histology [37].
Location
Microinfarcts occur throughout the brain [72]. However, in the five 
studies included here, four specifically aimed to study intracortical 
microinfarcts and one studied them in the context of CAA, which 
predominantly affects the cortex. It is therefore not unexpected that 
all microinfarcts identified in these studies were intra- cortical. They 
were seen in all layers, often in the most superficial layer [35] where 
they sometimes caused a small surface retraction [39], or extended 
to two or more layers [38,39]. They were more commonly seen in pa-
rietal and frontal cortex [38] and appeared to cluster on MRI [37]. In 
both CAA and VaD, they were often superficial [35]. Cerebellar mi-
croinfarcts were more common in VaD, where they were also associ-
ated with leptomeningeal arteriosclerosis [36]. Detailed histological 
assessment of 12 radiological juxtacortical microinfarcts revealed 
eight PVS, one primary haemorrhage and one venous angioma; two 
lesions were not identified [39].
In vivo imaging
In vivo 1.5T MRI was examined retrospectively in one paper and no 
microinfarcts were visible [37]. Another study found 15 possible mi-
croinfarcts on in vivo 7T MRI; four were identified on corresponding 
in vivo 3T T1 and/or T2 sequences but ex vivo MRI and histology 
were not undertaken [38].
Non- precise microinfarct comparisons
A number of microinfarcts seen on MR imaging as small, well- defined 
hyperintensities on T2, not visible on T2* were compared but not 
described histologically in two studies [35,36]. More microinfarcts 
were identified in cases with neurodegenerative pathology and CAA 
when compared with non- neurodegenerative brains [36].
Microinfarcts summary
• Twenty- six histological lesions were precisely matched to MR- 
identified microinfarcts.
• Histological appearances were variable, most often (in 54%) re-
vealing foci of chronic neuronal loss and gliosis; acute changes 
with red neurons and white matter pallor were seen in 23% 
(Figure 8).
• A significant number of microinfarcts identified on histology were 
too small to be seen on MRI up to 7T.
CAA
As stated, we excluded studies of only haemorrhagic pathology, 
which includes the bulk of reporting on CAA, a major cause of spon-
taneous intracerebral haemorrhage [73]. However, many studies 
did not describe subjects with amyloid and non- amyloid pathology 
separately and a number of lesions related to CAA were described 
within these studies, they are included here.
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CAA and radiological WML
Most histological studies found no association between cortical or 
leptomeningeal CAA and radiological WML [43,45,49,54,56,57]. 
One study of WML found no CAA in thickened hyalinised vessels 
[54]. Cortical and leptomeningeal CAA correlated with increased 
levels of the hypoxia marker HIF- 1α in deep subcortical WML only 
[60].
CAA and radiological PVS
One paper reported a significant positive relationship between se-
verity of histological cortical CAA and of radiological juxtacortical 
dilated PVS [42].
CAA and microinfarcts
Intracortical microinfarcts, rather than juxtacortical and deep white 
matter infarcts, may be associated with severe CAA [35,74]. The 
number of the smallest superficial cortical microinfarcts was in-
creased in Alzheimer's disease with CAA, and in VaD [35]. Seventy- 
two per cent of microinfarcts in one paper were associated with 
moderate to severe CAA; one- third of these were identified on ex 
vivo MRI. 48/48 cortical microinfarcts in subjects with CAA were 
associated with vascular abnormalities, 33 were close to amyloid- ß 
positive vessels and 15 to vessels showing ‘double- barrelling’ arte-
riopathy associated with CAA.
DISCUSSION
This review has highlighted the variability in methodology and re-
porting in radiological– pathological comparisons in sporadic human 
cerebral SVD. The earliest of these papers were published in the 
1980s when MR resolution was much less sensitive than it is today, 
and SVD knowledge was much less refined. There has since been 
a consensus on neuroimaging terminology and techniques [1], used 
in subsequent papers [37,39,42]. However, pathological terminology 
and reporting remains variable [75], limiting the reproducibility and 
interrogation of findings [76] and making it difficult to identify and 
interpret relevant literature (Table S1). As such, we recognise that 
some relevant studies may have been overlooked in this systematic 
review. Lesions were often poorly defined histologically, and some 
histological changes with unknown significance overlooked, such as 
venous collagenosis and fibrinoid necrosis. In particular, the term 
‘infarct’ is in common use histologically but the precise definition is 
lacking and, our results indicate, is inconsistent with the term used 
in vivo.
Tissue ‘oedema’ and PVS dilatation were frequently observed on 
histopathology in WMH; although these features have received less 
attention to date in the pathology literature than myelin loss, oedema 
and PVS dilation correspond with findings on in vivo MRI suggest-
ing that WMH (and the perilesional penumbra) have increased tis-
sue water and increased BBB leakage [77,78]. It also concurs with 
the reduction in WML seen in vivo at follow- up in some patients 
associated with reductions in brain tissue water [79]. Additionally, 
PVS dilation in subcortical tissues is associated with increased se-
verity of WML and other features of SVD and may reflect impaired 
tissue fluid and waste clearance [80]. Widespread signal changes 
are seen in post- mortem brains with neurodegenerative pathology, 
such as altered T2 [81] and R2 (transverse relaxation rate) [82] in 
multiple areas including white matter and may be associated with 
mild cognitive decline. However histological correlation is needed 
in more studies to understand the pathological substrate of these 
appearances.
Alterations in normal appearing white matter adjacent to SVD 
lesions are seen [44,45,59] including specific axonal alterations in 
nodes of Ranvier and paranodal regions adjacent to lacunar infarcts 
[83], but no studies that we are aware of have addressed histological 
gradients of abnormality around lesions.
Some studies describe risk factors for SVD, but clinical risk factors 
are generally under- reported and the full association with radiolog-
ical and pathological burden remains unclear [84]. Medical histories 
were usually collected retrospectively and therefore common vas-
cular risk factors are likely to be under- recognised. Cardiovascular 
risk factors are the most strongly associated modifiable risk factors 
for SVD, and WML were the focus of most radiological– pathological 
correlation studies assessed in this review. However, it should be 
noted that cardiovascular risk factors explain only 2% of the vari-
ance in WMH on imaging [85], and other potentially modifiable risk 
factors current remain unknown.
The importance of radiological– histological comparisons is well 
recognised [86]. However, a significant proportion of lesions, par-
ticularly microinfarcts, microbleeds and microvessel pathologies re-
main undetected on neuroimaging at current clinical field strengths 
[37] and this is reflected in the range of field strengths and slice 
thicknesses used in these studies. Higher field strengths, for exam-
ple 3T, reveal lesions for which we currently lack pathological com-
parative material and the technology required to accurately compare 
radiological and histological lesions.
Tissue storage and fixation times varied from overnight [56] to 
12 years [47]. Although no formal quality assessments were made, 
no changes were reported that affected the ability to assess the tis-
sue on post- mortem imaging or histology. Repeated and high field 
MRI examination of post- mortem tissue does not appear to compro-
mise histological examination but the interpretation of post- mortem 
MR images should consider differences in the superficial and deep 
aspects of tissue that have been submerged in formalin [87,88].
There is significant radiological and pathological heterogeneity 
in SVD. Advances in understanding of the clinical consequences of 
SVD with ageing have come from imaged cohorts followed over a life 
course (such as the RUN DMC study [89] and Lothian Birth Cohort 
1936 [90]), and the introduction of the STRIVE consensus stan-
dards for neuroimaging [1] has introduced a standardised approach 
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across neuroimaging SVD studies. Pathological studies now have to 
follow this established pathway. The number of direct radiological– 
pathological comparison studies to date are small, and of course, 
pathological studies are, by their nature, static. Radiological studies 
highlight the dynamic nature of SVD, and therefore the cohorts used 
to study SVD should be well- characterised clinical and radiological 
cohorts with brain donation programmes. Making precise compar-
isons is resource- intensive but possible [91]. Initiatives such as the 
Medical Research Council's UK Brain Bank Network [92] is helping 
to generate an accessible well- characterised brain tissue resource 
linked to detailed clinical and imaging data. Standardised histological 
approaches to assessing the contribution of SVD to an overall diag-
nosis of cognitive impairment have been published [2,23], and while 
the need to standardise the basic pathological protocols and de-
scriptions of SVD has been recognised [11], to date no standardised 
consensus statements have been published. To maximise gain from 
the valuable brain bank resources, future studies must be of high 
quality, with subjects characterised as fully as possible in vivo, and 
standardised methods of tissue assessment (both radiologically and 
histologically), using standardised terminology and reporting.
Standardised methods for processing post- mortem tissue should 
address artefact, particularly as MRI field strengths continue to in-
crease towards microscopic resolution [37]. These approaches need 
to account for post- mortem thrombi within vessels and air bubbles 
that can mimic small haemorrhagic lesions on ex vivo MRI [93], and 
the effects of heating during MRI on tissue quality and artefact. 
Brain tissue absorbs more radiofrequency than other tissue and in 
vivo mechanisms such as vasodilation, which usually dissipate heat 
[94], are absent. Tissue quality assessment is important as it reflects 
the potential for artefact, alters MR imaging properties [87] and is 
essential for further use of tissue, such as genetic assessment, a log-
ical extension of these studies [95].
This review is limited as it does not include individual case stud-
ies and abstracts not written in English. It is potentially limited by 
the search strategy applied and publication bias. However, this is the 
nature of systematic reviews and we do not believe we have missed 
any significant publications comparing radiological and histological 
appearances of SVD lesions. There are several animal models of 
SVD, but they do not fully represent the spectrum of disease, often 
simplifying the heterogeneity seen in human tissue. By specifying 
human studies, we have focussed on the disease in the appropri-
ate context. We have concentrated on sporadic SVD rather than 
monogenic causes which are a distinct subgroup with potentially 
overlapping pathophysiological mechanisms, but ultimately differ-
ent phenotypes. We have, however, included CAA as part of the 
spectrum of SVD, further increasing the heterogeneity. The lack of 
precise comparisons combined with sub- optimal MRI resolutions 
and inconsistent reporting makes it difficult to always be sure the 
exact same lesions were studied and therefore have confidence in 
the conclusions drawn. However, we have tried to distinguish com-
parisons of precise cellular features from more general appearances. 
Inconsistent reporting also made it difficult to compare the studies, 
resulting in somewhat lengthy lists and descriptive results which are 
difficult to read and we were unable to carry out a meta- analysis. 
However, this is a further reflection of the variability in SVD termi-
nology and methods.
Recently the dynamic nature of other SVD lesions including 
microinfarcts and lacunes has been appreciated [96]. WMH are dy-
namic on in vivo neuroimaging with varying outcomes [78,97,98]. 
These observations are, to date, not reflected in histological stud-
ies which provide only a static assessment of what are, most likely, 
end- stage tissue changes. In the studies in this review, the overall 
numbers of subjects and lesions is also very small. In future, com-
prehensive standardised reporting of clinical and pathological data, 
with precise comparison methods and advanced neuroimaging tech-
nologies are needed to study specific SVD lesions. In particular, 
attention to changes within and around radiological WMH should 
be studied; identifying the centre of a lesion and tracking changes 
in myelin and axons, for example, as it becomes normal appearing 
white matter; looking carefully for structural changes within normal 
appearing white matter that may be associated with WML burden. 
Comparing lesions in different locations and using prospective, 
comprehensive medical and lifestyle information will strengthen 
pathological– radiological– clinical associations, furthering our un-
derstanding of the pathological substrates and cellular mechanisms 
underlying SVD.
In summary, radiological– pathological correlation in human spo-
radic SVD is important, but standardised protocols and terminology 
in well- characterised clinical cohorts are required to truly use these 
correlations to advance our understanding of the pathophysiology 
of this common disorder. Using this systematic review and building 
on important definitions already published [2] we plan to undertake 
a multi- centre work to develop standardised definitions and grading 
systems that can be used to provide uniformity to future histopatho-
logical assessments of elements of sporadic SVD, similar to those 
developed by neuroimaging [99].
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